Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Income Statements (unaudited)

v3.21.1
Condensed Consolidated Income Statements (unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenues:    
Total revenues $ 17,547,965 $ 13,644,486
Cost of revenues:    
Total cost of revenues 1,765,317 1,486,155
Selling and marketing expenses 2,489,279 2,055,289
Depreciation and amortization 1,169,866 654,249
General and administrative expenses 10,087,060 8,694,250
Total selling, general and administrative expenses 13,746,205 11,403,788
Net loss on disposition or impairment 64,767 1,193
Income from operations 1,971,676 753,350
Other expense, net (21,537) (4,337)
Income before income tax benefit 1,950,139 749,013
Income tax benefit (364,148) (65,934)
Net income and comprehensive income 2,314,287 814,947
Less: income attributable to the non-controlling interest 0 0
Net income attributable to The Joint Corp. stockholders $ 2,314,287 $ 814,947
Earnings per share:    
Basic earnings per share (in dollars per share) $ 0.16 $ 0.06
Diluted earnings per share (in dollars per share) $ 0.16 $ 0.06
Basic weighted average shares (in shares) 14,178,542 13,890,673
Diluted weighted average shares (in shares) 14,854,809 14,483,584
Revenues from company-owned or managed clinics    
Revenues:    
Total revenues $ 9,470,860 $ 7,294,295
Royalty fees    
Revenues:    
Total revenues 4,769,246 3,718,230
Franchise fees/Franchise and regional development cost of revenues    
Revenues:    
Total revenues 695,427 512,751
Cost of revenues:    
Cost of revenues 1,624,572 1,417,491
Advertising fund revenue    
Revenues:    
Total revenues 1,374,741 1,057,618
Software fees/IT cost of revenues    
Revenues:    
Total revenues 760,537 645,725
Cost of revenues:    
Cost of revenues 140,745 68,664
Regional developer fees    
Revenues:    
Total revenues 217,956 207,642
Other revenues    
Revenues:    
Total revenues $ 259,198 $ 208,225